A 6-month safety and benefit study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6200 Pediatric Subjects 4-11 years old with Persistent Asthma

Grants and Contracts Details

StatusFinished
Effective start/end date12/24/126/30/14

Funding

  • Parexel International Co: $2,500.00